Los Angeles Capital Management
THC icon

Los Angeles Capital Management’s Tenet Healthcare THC Stock Holding History

Los Angeles Capital Management’s Portfolio THC Stock Details THC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$33.8M Buy
180,782
+107,697
+147% +$19.8M 0.12% 159
2026
Q1 		$13.8M Buy
73,085
+63,973
+702% +$13.5M 0.05% 220
2025
Q4 		$1.9M Sell
9,112
-47
-0.5% -$9.5K 0.01% 459
2025
Q3 		$1.86M Sell
9,159
-117,161
-93% -$20.8M 0.01% 523
2025
Q2 		$22.2M Buy
126,320
+1,509
+1% +$227K 0.08% 162
2025
Q1 		$16.8M Buy
124,811
+13,030
+12% +$1.72M 0.07% 180
2024
Q4 		$14.1M Buy
111,781
+89,287
+397% +$13.3M 0.06% 211
2024
Q3 		$3.74M Buy
+22,494
New +$3.4M 0.02% 349
2020
Q3 		– Sell
-93,758
Closed -$1.7M – 1526
2020
Q2 		$1.7M Sell
93,758
-2,640
-3% -$52K 0.01% 660
2020
Q1 		$1.39M Buy
96,398
+56,220
+140% +$1.61M 0.01% 632
2019
Q4 		$1.53M Buy
40,178
+29,284
+269% +$877K 0.01% 717
2019
Q3 		$241K Buy
+10,894
New +$232K ﹤0.01% 1176
2018
Q4 		– Sell
-43,746
Closed -$1.25M – 1378
2018
Q3 		$1.25M Buy
43,746
+23,855
+120% +$788K 0.01% 793
2018
Q2 		$668K Buy
+19,891
New +$618K ﹤0.01% 1045
2015
Q4 		– Sell
-16,918
Closed -$625K – 1174
2015
Q3 		$625K Sell
16,918
-732,784
-98% -$37.9M 0.01% 816
2015
Q2 		$43.4M Buy
749,702
+372,826
+99% +$19M 0.4% 62
2015
Q1 		$18.7M Buy
376,876
+347,437
+1,180% +$16.2M 0.17% 161
2014
Q4 		$1.49M Buy
29,439
+5,899
+25% +$308K 0.01% 555
2014
Q3 		$1.4M Sell
23,540
-64,357
-73% -$3.59M 0.02% 527
2014
Q2 		$4.13M Sell
87,897
-465,787
-84% -$21M 0.04% 373
2014
Q1 		$23.7M Sell
553,684
-66,531
-11% -$2.94M 0.26% 116
2013
Q4 		$26.1M Buy
620,215
+21,995
+4% +$958K 0.29% 109
2013
Q3 		$24.6M Buy
598,220
+184,124
+44% +$7.7M 0.3% 91
2013
Q2 		$19.1M Buy
+414,096
New +$18.5M 0.27% 103

Other funds holding THC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Los Angeles Capital Management's THC Position: Q2 2026 in Review

Los Angeles Capital Management increased its Tenet Healthcare (THC) stake by 147% in Q2 2026, buying an estimated $19.8M and bringing the position to 180,782 shares worth $33.8M. The position accounts for 0.12% of the portfolio, ranked #159.

Los Angeles Capital Management first reported a position in THC in Q2 2013 and has held it in 24 quarters since. The position peaked at $43.4M in Q2 2015. 681 funds tracked by Wall St. Rank hold THC as of Q2 2026.

  • Los Angeles Capital Management held 180,782 shares of Tenet Healthcare worth $33.8M as of Q2 2026.
  • Los Angeles Capital Management bought 107,697 Tenet Healthcare shares in Q2 2026, an estimated $19.8M.
  • Tenet Healthcare made up 0.12% of Los Angeles Capital Management's portfolio in Q2 2026, its #159 holding.
  • Los Angeles Capital Management first reported a position in Tenet Healthcare in Q2 2013 and has held it in 24 quarters since.
  • Los Angeles Capital Management's Tenet Healthcare position peaked at $43.4M in Q2 2015.
  • 681 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on Los Angeles Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.